GENTEL BIOSCIENCES
Gentel Biosciences, Inc., a protein chip-based life sciences company, develops and manufactures biochip products in the United States. Its products include PATH, a protein microarray surface for multiplex immunoassays; SIMplex multiplexing system that allows the processing of individual microarrays on a nitrocellulose microarray slide; SPRgold substrates for use with SPR imaging; PANDEIA, a protein labeling and fluorescent detection system; and APiX View Detection Kits for ultra-sensitive chromo... genic detection of protein microarrays. The company also provides custom arraying, sample processing, and custom assay development services. It offers products through distributors in Japan and Germany. The company was formerly known as GenTel BioSurfaces Inc. and changed its name to Gentel Biosciences, Inc. in May 2008. The company was founded in 2000 and is based in Madison, Wisconsin. As of May 15, 2013, Gentel Biosciences, Inc. operates as a subsidiary of Intuitive Biosciences, Inc.
GENTEL BIOSCIENCES
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2000-01-01
Address:
Madison, Wisconsin, United States
Country:
United States
Website Url:
http://www.gentelbio.com
Total Employee:
1+
Status:
Active
Total Funding:
2.74 M USD
Technology used in webpage:
Domain Not Resolving Euro DreamHost Hosting ClouDNS
Current Employees Featured
Founder
Official Site Inspections
http://www.gentelbio.com
- Host name: 159.203.27.76
- IP address: 159.203.27.76
- Location: Toronto Canada
- Latitude: 43.6547
- Longitude: -79.3623
- Timezone: America/Toronto
- Postal: M5A
More informations about "Gentel Biosciences"
Gentel Biosciences – Biosurfaces, Microarrays for …
The Taq Pro Universal SYBR qPCR Master Mix is a high-performance reagent designed for quantitative PCR (qPCR) applications. This ready-to-use mix enables the amplification and detection of DNA in real-time, making it a …See details»
GenTel BioSciences Company Profile | Management and
Www.gentelbio.com . GenTel BioSciences Profile and History. Gentel® Biosciences, Inc. provides protein microarray products and services to life science researchers worldwide. The …See details»
Gentel Biosciences - Crunchbase Company Profile & Funding
Gentel Biosciences, Inc., a protein chip-based life sciences company, develops and manufactures biochip products in the United States. Its products include PATH, a protein microarray surface …See details»
GENTEL BIOSURFACES, INC. - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Gentel Biosciences, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Gentel Biosciences, Inc. with its drug pipeline, therapeutic area, technology platform, 1 literature.See details»
GenTel BioSciences - Overview, News & Similar companies
View GenTel BioSciences (www.gentelbio.com) location in Wisconsin, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Gentel Biosciences Company Profile 2024: Valuation, Investors ...
Information on acquisition, funding, investors, and executives for Gentel Biosciences. Use the PitchBook Platform to explore the full profile.See details»
Contact us – Gentel Biosciences
Taq Pro Universal SYBR qPCR Master Mix: A Comprehensive Overview; AffiAAV® in Gene Therapy Research; Yersinia pestis Recombinants; Shigella flexneri RecombinantsSee details»
GenTel BioSciences Inc Overview - Salary.com
Discover essential details about GenTel BioSciences Inc, including address, contact, and journey of our company's evolution.See details»
How much do GenTel BioSciences Inc employees make? - Salary.com
The average annual salary of GenTel BioSciences Inc is estimated to be approximate $92,369 per year. The majority pay is between $81,372 to $104,319 per year. Visit Salary.com to find out …See details»
Gentel Biosciences, Inc. - Madison, Wisconsin (WI) - BiosciRegister
Profile: Gentel Biosciences, Inc. offers multiplex protein analysis products and services.We provide APiX™96 protein microarray, Path® slides, SIMplex™ multiplexing systems, …See details»
Gentel Biosciences | Lab Animal Buyers' Guide
ISSN: 0093-7355 EISSN: 1548-4475. Journal Home | Current issue | Archive | Buyers' Guide | Instructions for authors | About the journal | Subscription information ...See details»
GenTel BioSciences - Products, Competitors, Financials, Employees ...
Feb 3, 2014 Solidus Biosciences. Solidus Biosciences is a company that provides business intelligence for the pharmaceutical and biopharmaceutical sectors. Their offerings include …See details»
GentiBio - Crunchbase Company Profile & Funding
GentiBio is a biotherapeutics company developing engineered regulatory T cells (EngTregs) programmed to treat autoimmune allergic diseases. The early-stage biotherapeutics company …See details»
ONCOaccu Panel NGeneBio – Gentel Biosciences
Blog Shigella flexneri Recombinants Introduction The PhoP/PhoQ two-component signal transduction system is an important regulator of stress responses and virulence in most gram …See details»
GenTel BioSciences, Inc. and Van Andel Institute Announce
Grand Rapids, Mich. (March 24, 2011) – Gentel Biosciences, a leader in proteomics tools, and Van Andel Research Institute (VARI), a biomedical research institute, jointly announce today …See details»
GentiBio Company Profile - Craft
GentiBio has 5 employees at their 1 location and $20 m in total funding,. See insights on GentiBio including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
GentiBio - VentureRadar
Similar Companies: Sonoma Therapeutics USA Privately Held Sonoma Biotherapeutics is an immune tolerance company developing engineered regulatory T cell (Treg) therapies to treat …See details»
Zeptometrix NATtrol Meningitis Encephalitis Panel
PRODUCT DESCRIPTION: NATtrol Meningitis/Encephalitis (ME) Controls (NATMECBIO)* are formulated with purified, intact virus particles, bacterial and fungal cells which have been …See details»
GentiBio Launches with $20M Seed Funding from OrbiMed, …
Aug 5, 2020 BOSTON, SEATTLE and QIRYAT SHMONA, Israel, Aug. 5, 2020 /PRNewswire/ -- GentiBio, Inc., an emerging biotherapeutics company developing engineered regulatory T cells …See details»